Literature DB >> 17412298

Human parvovirus B19 infection and antiphospholipid antibodies.

Philipp von Landenberg1, Hartwig W Lehmann, Susanne Modrow.   

Abstract

Erythema infectiosum is the main manifestation of human parvovirus B19 infections. Further B19-related diseases commonly associated with the acute infection are flue-like symptoms, transient aplastic crisis, transient arthralgias, leukopenia and thrombocytopenia, spontaneous abortion and hydrops fetalis in pregnant women. Hepatitis, myocarditis, meningitis, encephalitis as well as pure red cell anemia may occur occasionally. In addition parvovirus B19 infections have been frequently described as cause or trigger of various forms of autoimmune diseases affecting all blood cell lines, joints, connective tissue, uvea, large and small vessels. Molecular mimicry may be one major contribution to the appearance of autoimmune antibodies, f.e. antiphospholipid and antineutrophil cytoplasmic antibodies as well as antinuclear antigens. These mechanisms implicated in the pathogenesis of parvovirus B19 triggered autoimmune diseases, especially focused on the development of antiphospholipid antibodies will be discussed in this short review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17412298     DOI: 10.1016/j.autrev.2006.09.006

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  15 in total

1.  Pregnancy and catastrophic antiphospholipid syndrome.

Authors:  Jose A Gómez-Puerta; Jose Sanin-Blair; Claudio Galarza-Maldonado
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

2.  Anti-Self Phosphatidylserine Antibodies Recognize Uninfected Erythrocytes Promoting Malarial Anemia.

Authors:  Cristina Fernandez-Arias; Juan Rivera-Correa; Julio Gallego-Delgado; Rachel Rudlaff; Clemente Fernandez; Camille Roussel; Anton Götz; Sandra Gonzalez; Akshaya Mohanty; Sanjib Mohanty; Samuel Wassmer; Pierre Buffet; Papa Alioune Ndour; Ana Rodriguez
Journal:  Cell Host Microbe       Date:  2016-02-10       Impact factor: 21.023

Review 3.  Advances in human B19 erythrovirus biology.

Authors:  Annabelle Servant-Delmas; Jean-Jacques Lefrère; Frédéric Morinet; Sylvie Pillet
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

Review 4.  ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.

Authors:  Aysegul Nalca; Elizabeth E Zumbrun
Journal:  Drug Des Devel Ther       Date:  2010-05-25       Impact factor: 4.162

5.  Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen.

Authors:  Bor-Show Tzang; Der-Yuan Chen; Chun-Chou Tsai; Szu-Yi Chiang; Tsung-Ming Lin; Tsai-Ching Hsu
Journal:  J Biomed Sci       Date:  2010-05-25       Impact factor: 8.410

6.  Does parvovirus infection have a role in systemic lupus erythematosus?

Authors:  Tami Hod; Giselle Zandman-Goddard; Pnina Langevitz; Hagit Rudnic; Zehava Grossman; Pnina Rotman-Pikielny; Yair Levy
Journal:  Immunol Res       Date:  2017-04       Impact factor: 4.505

7.  Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression.

Authors:  Francesca Bonvicini; Elisabetta Manaresi; Francesca Di Furio; Luisa De Falco; Giorgio Gallinella
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

Review 8.  Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodies.

Authors:  Konstantin N Konstantinov; Suzanne N Emil; Marc Barry; Susan Kellie; Antonios H Tzamaloukas
Journal:  ISRN Nephrol       Date:  2013-02-19

9.  Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.

Authors:  Kanoktip Thammasri; Sanna Rauhamäki; Liping Wang; Artemis Filippou; Violetta Kivovich; Varpu Marjomäki; Stanley J Naides; Leona Gilbert
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

10.  Increased expression of Matrix Metalloproteinase 9 in liver from NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein.

Authors:  Chun-Chou Tsai; Bor-Show Tzang; Szu-Yi Chiang; Gwo-Jong Hsu; Tsai-Ching Hsu
Journal:  J Biomed Sci       Date:  2009-01-26       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.